Adhesion force sensing and activation of a membrane-bound sensor to activate nisin efflux pumps in Staphylococcus aureus under mechanical and chemical stresses

Autor: Carniello, Vera, Harapanahalli, Akshay K., Busscher, Henk J., van der Mei, Henny C.

Publikováno v: In Journal of Colloid And Interface Science 15 February 2018 512:14-20

Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor

Autor: Prakash, Jai, Beljaars, Leonie, Harapanahalli, Akshay K., Zeinstra-Smith, Mieke, De Jager-Krikken, Alie, Hessing, Martin, Steen, Herman, Poelstra, Klaas

Publikováno v: International Journal of Cancer, 126(8), 1966-1981. Wiley
International journal of cancer, 126(8), 1966-1981. Wiley

Tumor-targeting of anticancer drugs is an interesting approach for the treatment of cancer since chemotherapies possess several adverse effects. In the present study, we propose a novel strategy to deliver anticancer drugs to the tumor cells through

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dd43c6cb8f384b90894a632e72e07b75
https://research.rug.nl/en/publications/756cda2d-b4b4-4532-8086-1edb2817df73

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor.

Autor: Prakash J; Department of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands.; BiOrion Technologies BV, Groningen, The Netherlands., Beljaars L; Department of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands., Harapanahalli AK; Department of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands., Zeinstra-Smith M; Department of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands.; BiOrion Technologies BV, Groningen, The Netherlands., de Jager-Krikken A; Department of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands., Hessing M; BiOrion Technologies BV, Groningen, The Netherlands., Steen H; BiOrion Technologies BV, Groningen, The Netherlands., Poelstra K; Department of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands.; BiOrion Technologies BV, Groningen, The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2010 Apr 15; Vol. 126 (8), pp. 1966-1981.